DAVION HEALTHCARE PLC (DAVI) Form 6-K — Oct 20, 2026
Davion Healthcare Plc announced its ordinary shares are expected to begin trading on the Nasdaq Global Market on October 22, 2026 under the ticker symbol DAVI, with Maxim Group LLC acting as financial advisor on the listing. Alongside the listing, the company announced a leadership transition: Glenn Williams becomes CEO and Jeremy North becomes COO, while current CEO Jack Kaye moves to Chairman and Sir Eric Peacock steps down as Chairman but stays on the Board. Salaries were set at $600,000 for the Chairman, $516,000 for the CEO and $420,000 for the COO.
Key figures
- Nasdaq ticker
- DAVI
- Ceo salary usd
- 516000
- Coo salary usd
- 420000
- Chairman salary usd
- 600000
- Nasdaq listing date
- 2026-10-22
- Acquisition bond gbp
- £30 million five-year senior secured bond
- Williams ma experience
- more than $1 billion of M&A and due-diligence activity
- Care finders sale value
- more than $350 million
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.